LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article: Recent advances in nanomaterials based biosensors for point of care (PoC) diagnosis of Covid-19 - A minireview.

    Gowri, Annasamy / Ashwin Kumar, N / Suresh Anand, B S

    Trends in analytical chemistry : TRAC

    2021  Volume 137, Page(s) 116205

    Abstract: ... in the development of affordable PoC diagnostic platforms for rapid and accurate diagnosis of COVID-19. First ... facilities. In this context, the point of care (PoC) diagnostic platform has proven to be the prospective ... advances in the development of PoC biosensors, including lateral flow immunoassays and other emerging ...

    Abstract Early diagnosis and ultrahigh sample throughput screening are the need of the hour to control the geological spread of the COVID-19 pandemic. Traditional laboratory tests such as enzyme-linked immunosorbent assay (ELISA), reverse transcription polymerase chain reaction (RT-PCR) and computed tomography are implemented for the detection of COVID-19. However, they are limited by the laborious sample collection and processing procedures, longer wait time for test results and skilled technicians to operate sophisticated facilities. In this context, the point of care (PoC) diagnostic platform has proven to be the prospective approach in addressing the abovementioned challenges. This review emphasizes the mechanism of viral infection spread detailing the host-virus interaction, pathophysiology, and the recent advances in the development of affordable PoC diagnostic platforms for rapid and accurate diagnosis of COVID-19. First, the well-established optical and electrochemical biosensors are discussed. Subsequently, the recent advances in the development of PoC biosensors, including lateral flow immunoassays and other emerging techniques, are highlighted. Finally, a focus on integrating nanotechnology with wearables and smartphones to develop smart nanobiosensors is outlined, which could promote COVID-19 diagnosis accessible to both individuals and the mass population at patient care.
    Language English
    Publishing date 2021-01-28
    Publishing country Netherlands
    Document type Journal Article ; Review
    ZDB-ID 2014041-1
    ISSN 0165-9936
    ISSN 0165-9936
    DOI 10.1016/j.trac.2021.116205
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Recent advances in nanomaterials based biosensors for point of care (PoC) diagnosis of Covid-19 – A minireview

    Gowri, Annasamy / Ashwin Kumar, N. / Suresh Anand, B.S.

    Trends in analytical chemistry. 2021 Apr., v. 137

    2021  

    Abstract: ... in the development of affordable PoC diagnostic platforms for rapid and accurate diagnosis of COVID-19. First ... facilities. In this context, the point of care (PoC) diagnostic platform has proven to be the prospective ... advances in the development of PoC biosensors, including lateral flow immunoassays and other emerging ...

    Abstract Early diagnosis and ultrahigh sample throughput screening are the need of the hour to control the geological spread of the COVID-19 pandemic. Traditional laboratory tests such as enzyme-linked immunosorbent assay (ELISA), reverse transcription polymerase chain reaction (RT-PCR) and computed tomography are implemented for the detection of COVID-19. However, they are limited by the laborious sample collection and processing procedures, longer wait time for test results and skilled technicians to operate sophisticated facilities. In this context, the point of care (PoC) diagnostic platform has proven to be the prospective approach in addressing the abovementioned challenges. This review emphasizes the mechanism of viral infection spread detailing the host-virus interaction, pathophysiology, and the recent advances in the development of affordable PoC diagnostic platforms for rapid and accurate diagnosis of COVID-19. First, the well-established optical and electrochemical biosensors are discussed. Subsequently, the recent advances in the development of PoC biosensors, including lateral flow immunoassays and other emerging techniques, are highlighted. Finally, a focus on integrating nanotechnology with wearables and smartphones to develop smart nanobiosensors is outlined, which could promote COVID-19 diagnosis accessible to both individuals and the mass population at patient care.
    Keywords COVID-19 infection ; analytical chemistry ; biosensors ; computed tomography ; early diagnosis ; enzyme-linked immunosorbent assay ; host-pathogen relationships ; mobile telephones ; pathophysiology ; point-of-care systems ; reverse transcriptase polymerase chain reaction
    Language English
    Dates of publication 2021-04
    Publishing place Elsevier B.V.
    Document type Article
    ZDB-ID 2014041-1
    ISSN 0165-9936
    ISSN 0165-9936
    DOI 10.1016/j.trac.2021.116205
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

To top